HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Options for prolonging the hypotensive effect of trabeculectomy].

AbstractOBJECTIVE:
To assess potential of preoperative therapy with local steroid and non-steroid anti-inflammatory drugs (SAIDs and NSAIDs) for prolonging the hypotensive effect of trabeculectomy.
MATERIAL AND METHODS:
A total of 80 patients with primary open-angle glaucoma planed for trabeculectomy were randomized into 4 groups of 20 each: 3 groups that differed in the studied drug (nepafenac, dexamethasone, or their non-fixed combination) and a control group with no preoperative therapy. The patients instilled 1 drop of either drug b.i.d. for 2 weeks before the surgery and were examined each day of the first week and then at weeks 1, 2, 4 and months 3, 6, and 12. The rate of postoperative surgical and medical interventions (needling, needling revision, hypotensive therapy) was used for outcome evaluation.
RESULTS:
Postoperative needling was required in 50% of the controls, 35% of the NSAIDs and 30% of the SAIDs patients as well as 20% the combination-therapy patients. Needling revision had to be performed in 10% of patients from the control group and 5% of patients from the NSAIDs group. Patients from the steroid and combination-therapy groups had no need in needling procedure. Further hypotensive therapy was required in 50% of the control group, 35% of the NSAIDs group, 25% of the SAIDs group and 20% of the combination-therapy group. During the first postoperative year complete success of the treatment was achieved in 50% of the controls, 65% of the NSAIDs patients, 75% of the SAIDs patients, and 80% of those under combination therapy. Qualified success during the same period was achieved in 100% of cases.
CONCLUSION:
Preoperative local anti-inflammatory therapy helped to increase the one-year complete success rate after trabeculectomy as compared with the controls. The most significant hypotensive effect was noted in the combination-therapy group (80%), less significant--in the steroid and non-steroid monotherapy groups (75% and 65% correspondingly). A negative correlation was noted between the use of nepafenac and dexamethasone and other measures aimed at increasing the hypotensive effect of glaucoma surgery.
AuthorsS Yu Petrov, А А Antonov, А S Makarova, S V Vostrukhin, D М Safonova
JournalVestnik oftalmologii (Vestn Oftalmol) 2015 Jan-Feb Vol. 131 Issue 1 Pg. 75-81 ISSN: 0042-465X [Print] Russia (Federation)
PMID25872390 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antihypertensive Agents
  • Benzeneacetamides
  • Glucocorticoids
  • Ophthalmic Solutions
  • Phenylacetates
  • nepafenac
  • Dexamethasone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Antihypertensive Agents (therapeutic use)
  • Benzeneacetamides (administration & dosage)
  • Dexamethasone (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glaucoma, Open-Angle (drug therapy, physiopathology, surgery)
  • Glucocorticoids (administration & dosage)
  • Humans
  • Intraocular Pressure (drug effects)
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Phenylacetates (administration & dosage)
  • Postoperative Care (methods)
  • Retrospective Studies
  • Trabeculectomy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: